ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · Real-Time Price · USD
1.799
+0.069 (4.01%)
Nov 21, 2024, 1:00 PM EST - Market open
ESSA Pharma Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
Selling, General & Admin | 11.63 | 10.81 | 12.54 | 12.88 | 11.37 | 5.46 | |
Research & Development | 22.25 | 21.32 | 24.42 | 24.26 | 12.15 | 6.7 | |
Operating Expenses | 33.88 | 32.13 | 36.96 | 37.14 | 23.52 | 12.15 | |
Operating Income | -33.88 | -32.13 | -36.96 | -37.14 | -23.52 | -12.15 | |
Interest Expense | -0 | -0.01 | -0.01 | -0.01 | -0.22 | -0.6 | |
Interest & Investment Income | 6.21 | 5.55 | 1.74 | 0.23 | 0.56 | 0.03 | |
Currency Exchange Gain (Loss) | -0 | 0.01 | 0 | -0.02 | -0.04 | 0.01 | |
Other Non Operating Income (Expenses) | - | - | 0.02 | 0.09 | -0.5 | 0 | |
EBT Excluding Unusual Items | -27.67 | -26.58 | -35.22 | -36.84 | -23.73 | -12.72 | |
Pretax Income | -27.67 | -26.58 | -35.22 | -36.84 | -23.73 | -12.72 | |
Income Tax Expense | - | 0 | -0.11 | -0.03 | -0.29 | 0.04 | |
Net Income | -27.67 | -26.58 | -35.1 | -36.81 | -23.45 | -12.76 | |
Net Income to Common | -27.67 | -26.58 | -35.1 | -36.81 | -23.45 | -12.76 | |
Shares Outstanding (Basic) | 44 | 44 | 44 | 38 | 22 | 8 | |
Shares Outstanding (Diluted) | 44 | 44 | 44 | 38 | 22 | 8 | |
Shares Change (YoY) | 0.28% | 0.12% | 14.44% | 71.45% | 166.13% | 84.68% | |
EPS (Basic) | -0.63 | -0.60 | -0.80 | -0.96 | -1.04 | -1.51 | |
EPS (Diluted) | -0.63 | -0.60 | -0.80 | -0.96 | -1.04 | -1.51 | |
Free Cash Flow | -23.84 | -19.78 | -28 | -25.42 | -16.98 | -12.25 | |
Free Cash Flow Per Share | -0.54 | -0.45 | -0.64 | -0.66 | -0.76 | -1.45 | |
EBITDA | - | - | - | - | -23.5 | -12.13 | |
D&A For EBITDA | - | - | - | - | 0.02 | 0.02 | |
EBIT | -33.88 | -32.13 | -36.96 | -37.14 | -23.52 | -12.15 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.